Search Results - "Huestis, M A"

Refine Results
  1. 1

    Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites by Diao, X, Huestis, MA

    Published in Clinical pharmacology and therapeutics (01-02-2017)
    “…We review approaches for determining metabolism of new synthetic cannabinoids (SCs), and challenges and advances in identifying optimal urinary marker…”
    Get full text
    Journal Article
  2. 2

    Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay by Lee, M R, Scheidweiler, K B, Diao, X X, Akhlaghi, F, Cummins, A, Huestis, M A, Leggio, L, Averbeck, B B

    Published in Molecular psychiatry (01-01-2018)
    “…Oxytocin (OT) is a potential treatment for multiple neuropsychiatric disorders. As OT is a peptide, delivery by the intranasal (IN) route is the preferred…”
    Get full text
    Journal Article
  3. 3

    Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers by Hirvonen, J, Goodwin, R S, Li, C-T, Terry, G E, Zoghbi, S S, Morse, C, Pike, V W, Volkow, N D, Huestis, M A, Innis, R B

    Published in Molecular psychiatry (01-06-2012)
    “…Chronic cannabis (marijuana, hashish) smoking can result in dependence. Rodent studies show reversible downregulation of brain cannabinoid CB 1 (cannabinoid…”
    Get full text
    Journal Article
  4. 4

    Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration by Karschner, EL, Darwin, WD, McMahon, RP, Liu, F, Wright, S, Goodwin, RS, Huestis, MA

    Published in Clinical pharmacology and therapeutics (01-03-2011)
    “…Sativex is a cannabis‐plant extract delivering nearly 1:1 Δ9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) by oromucosal spray. It has been suggested that…”
    Get full text
    Journal Article
  5. 5

    Designer Drugs 2.0 by Huestis, MA, Tyndale, RF

    Published in Clinical pharmacology and therapeutics (01-02-2017)
    “…This “Designer Drugs 2.0” issue of Clinical Pharmacology & Therapeutics focuses on novel psychoactive substances, primarily cannabinoids and cathinones, and…”
    Get full text
    Journal Article
  6. 6

    THC and CBD blood and brain concentrations following daily administration to adolescent primates by Withey, S.L., Bergman, J., Huestis, M.A., George, S.R., Madras, B.K.

    Published in Drug and alcohol dependence (01-08-2020)
    “…•Adolescent primates dosed daily show stable THC, CBD blood levels for 4 months.•Pharmacokinetic tolerance does not develop to THC or CBD.•CBD did not modulate…”
    Get full text
    Journal Article
  7. 7

    Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes by Kacinko, SL, Jones, HE, Johnson, RE, Choo, RE, Huestis, MA

    Published in Clinical pharmacology and therapeutics (01-11-2008)
    “…For the first time, relationships among maternal buprenorphine dose, meconium buprenorphine and metabolite concentrations, and neonatal outcomes are reported…”
    Get full text
    Journal Article
  8. 8

    Delayed emergence of methamphetamine’s enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence by Vaupel, D.B, Schindler, C.W, Chefer, S, Belcher, A.M, Ahmet, I, Scheidweiler, K.B, Huestis, M.A, Stein, E.A

    Published in Drug and alcohol dependence (01-02-2016)
    “…Highlights • The cardiovascular effects of methamphetamine were evaluated in rhesus monkeys. • The monkeys had long histories of intravenous methamphetamine…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol by Huestis, M A

    “…Increasing interest in the biology, chemistry, pharmacology, and toxicology of cannabinoids and in the development of cannabinoid medications necessitates an…”
    Get more information
    Journal Article
  10. 10

    Differentiating New Marijuana Use From Residual Drug Excretion in Occasional Marijuana Users by Huestis, Marilyn A., Cone, Edward J.

    Published in Journal of analytical toxicology (01-10-1998)
    “…Increases in urine drug concentration that result from changes in urinary output may be mistakenly interpreted as new drug use rather than carryover from…”
    Get full text
    Journal Article
  11. 11

    Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath by Hubbard, J A, Hoffman, M A, Ellis, S E, Sobolesky, P M, Smith, B E, Suhandynata, R T, Sones, E G, Sanford, S K, Umlauf, A, Huestis, M A, Grelotti, D J, Grant, I, Marcotte, T D, Fitzgerald, R L

    Published in Journal of analytical toxicology (01-10-2021)
    “…Abstract Proving driving under the influence of cannabis (DUIC) is difficult. Establishing a biomarker of recent use to supplement behavioral observations may…”
    Get full text
    Journal Article
  12. 12

    Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation by Krasnova, I.N, Ladenheim, B, Jayanthi, S, Oyler, J, Moran, T.H, Huestis, M.A, Cadet, J.L

    Published in Neuroscience (01-01-2001)
    “…In order to examine differential strain susceptibility to neurotoxic effects of amphetamine and to assess the potential role of superoxide radicals in…”
    Get full text
    Journal Article
  13. 13

    Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans by Huestis, M.A, Cone, E.J, Pirnay, S.O, Umbricht, A, Preston, K.L

    Published in Drug and alcohol dependence (01-08-2013)
    “…Abstract Background Prescribed sublingual (SL) buprenorphine is sometimes diverted for intravenous (IV) abuse, but no human pharmacokinetic data are available…”
    Get full text
    Journal Article
  14. 14

    Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse by Lehrmann, E, Oyler, J, Vawter, M P, Hyde, T M, Kolachana, B, Kleinman, J E, Huestis, M A, Becker, K G, Freed, W J

    Published in The pharmacogenomics journal (01-01-2003)
    “…CNS-focused cDNA microarrays were used to examine gene expression profiles in dorsolateral prefrontal cortex (dlPFC, Area 46) from seven individual sets of…”
    Get full text
    Journal Article
  15. 15

    Selection and Optimization of Hydrolysis Conditions for the Quantification of Urinary Metabolites of MDMA by Pirnay, Stephane O., Abraham, Tsadik T., Lowe, Ross H., Huestis, Marilyn A.

    Published in Journal of analytical toxicology (01-10-2006)
    “…Recovery of 3,4-methylenedioxymethamphetamine (MDMA) urinary metabolites requires optimization of the hydrolysis of 4-hydroxy-3-methyoxymethamphetamine (HMMA),…”
    Get full text
    Journal Article
  16. 16

    Monitoring Opiate Use in Substance Abuse Treatment Patients With Sweat and Urine Drug Testing by Huestis, Marilyn A., Cone, Edward J., Wong, Conrad J., Umbricht, Annie, Preston, Kenzie L.

    Published in Journal of analytical toxicology (01-10-2000)
    “…Although urine testing remains the standard for drug use monitoring, sweat testing for drugs of abuse is increasing, especially in criminal justice programs…”
    Get full text
    Journal Article
  17. 17

    Identification of Hydrocodone in Human Urine Following Controlled Codeine Administration by Oyler, Jonathan M., Cone, Edward J., Joseph, Robert E., Huestis, Marilyn A.

    Published in Journal of analytical toxicology (01-10-2000)
    “…Allegations of illicit hydrocodone use have been made against individuals who were taking physician-prescribed oral codeine but denied hydrocodone use. Drug…”
    Get full text
    Journal Article
  18. 18

    Detection times of marijuana metabolites in urine by immunoassay and GC-MS by Huestis, M A, Mitchell, J M, Cone, E J

    Published in Journal of analytical toxicology (01-10-1995)
    “…Reports of prolonged drug excretion have provided the basis for the common assumption that cannabinoid metabolites may he detected in urine for a week or…”
    Get more information
    Journal Article
  19. 19

    Monitoring Cocaine Use in Substance-Abuse-Treatment Patients by Sweat and Urine Testing by Preston, Kenzie L., Huestis, Marilyn A., Wong, Conrad J., Umbricht, Annie, Goldberger, Bruce A., Cone, Edward J.

    Published in Journal of analytical toxicology (01-09-1999)
    “…Sweat and urine specimens were collected from 44 methadone-maintenance patients to evaluate the use of sweat testing to monitor cocaine use. Paired sweat…”
    Get full text
    Journal Article
  20. 20

    Early-onset cannabis use and cognitive deficits: what is the nature of the association? by Pope, Harrison G, Gruber, Amanda J, Hudson, James I, Cohane, Geoffrey, Huestis, Marilyn A, Yurgelun-Todd, Deborah

    Published in Drug and alcohol dependence (01-04-2003)
    “…Background: Individuals who initiate cannabis use at an early age, when the brain is still developing, might be more vulnerable to lasting neuropsychological…”
    Get full text
    Journal Article